NCT05162326View on ClinicalTrials.gov

BC-101 in Treatment of Nasolabial Fold Wrinkles

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

February 20, 2027

Conditions
Nasolabial Fold Wrinkles
Interventions
BIOLOGICAL

BC-101

Human umbilical cord tissue derived mesenchymal stem cells (hUC-MSC) suspension at concentration of 2, 4, or 6 million cells/mL.

Sponsors

Lead Sponsor

Bright Cell, Inc.
All Listed Sponsors
lead

Bright Cell, Inc.

INDUSTRY